Tangible Screening Compounds from OTAVA
| hal.structure.identifier | Centre d'Etudes Nucléaires de Bordeaux Gradignan [CENBG] | |
| dc.contributor.author | ANDREY, Dmytrenko | |
| dc.date.created | 2013-11-26 | |
| dc.date.issued | 2013-11-26 | |
| dc.description | A tangible compound repository is a very important source of exclusive organic molecules for screening projects in drug discovery. Tangible compounds denote molecules that are chemically feasible and having a high likelihood of being synthesized. Typically these are compounds that can be produced with synthetic schemes that have been validated. | |
| dc.description.abstractEn | A tangible compound repository is a very important source of exclusive organic molecules for screening projects in drug discovery. Tangible compounds denote molecules that are chemically feasible and having a high likelihood of being synthesized. Typically these are compounds that can be produced with synthetic schemes that have been validated. OTAVA Ltd. offers a collection of novel Tangible Screening Compounds including about 500,000 structures. The novel screening compounds ordered from this collection could be individually synthesized and delivered within 4 weeks. The compounds' purity is not less than 90% which can be validated by several methods: NMR and GC/LC/MS. NMR spectra are available upon request. Packaging of ordered compounds can be done in deep-well plates or bar-coded vials, weighing out is free. Tangible Screening Compounds from OTAVA is a unique opportunity to enrich your company's screening collection with molecules which are not available from other vendors. More information about OTAVA's novel screening compounds you can find at the web-site www.otavachemicals.com. | |
| dc.language.iso | en | |
| dc.subject.en | Tangible Screening Compounds | |
| dc.subject.en | drug discovery | |
| dc.subject.en | organic molecules | |
| dc.title.en | Tangible Screening Compounds from OTAVA | |
| dc.type | Autre document | |
| dc.subject.hal | Informatique [cs]/Biotechnologie | |
| dc.subject.hal | Sciences du Vivant [q-bio]/Biotechnologies | |
| hal.identifier | hal-00909272 | |
| hal.version | 1 | |
| hal.audience | Non spécifiée | |
| hal.origin.link | https://hal.archives-ouvertes.fr//hal-00909272v1 | |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.date=2013-11-26&rft.au=ANDREY,%20Dmytrenko&rft.genre=unknown |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||